Cargando…

Editorial: Novel mechanism and strategies to overcome relapse after allogeneic stem cell transplantation

Detalles Bibliográficos
Autores principales:	Sun, Yao, Zhang, Xiaohui, Hu, Liangding, Abid, Muhammad Bilal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368394/ https://www.ncbi.nlm.nih.gov/pubmed/37497215 http://dx.doi.org/10.3389/fimmu.2023.1248270

Ejemplares similares

Novel strategies to prevent and overcome relapse after allogeneic hematopoietic cell transplantation in acute lymphoblastic leukemia
por: Hodroj, Mohammad Hassan, et al.
Publicado: (2023)

Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD
por: Yao, Sun, et al.
Publicado: (2021)

Strategies for overcoming bottlenecks in allogeneic CAR-T cell therapy
por: Lv, Zixin, et al.
Publicado: (2023)

Editorial: The mechanism and novel strategies of overcoming resistance of hematological malignancies to CAR-T cell killing
por: Zhang, Tingting, et al.
Publicado: (2022)

Editorial: Gastrointestinal cancer immunotherapy: from drug resistance mechanisms to overcoming strategies
por: Shi, Tao, et al.
Publicado: (2023)

Azacitidine and lenalidomide combination: a novel relapse prophylaxis regimen after allogeneic hematopoietic stem-cell transplantation in patients with acute myeloid leukemia
por: Feng, Yimei, et al.
Publicado: (2023)

The Role of Immune Checkpoint Molecules for Relapse After Allogeneic Hematopoietic Cell Transplantation
por: Köhler, Natalie, et al.
Publicado: (2021)

Editorial: Immune Tolerance Post Allogeneic Hematopoietic Cell Transplantation
por: Schneidawind, Dominik, et al.
Publicado: (2020)

Novel Biomarkers for Outcome After Allogeneic Hematopoietic Stem Cell Transplantation
por: Chen, Sophia, et al.
Publicado: (2020)

Autoimmunity Following Allogeneic Hematopoietic Stem Cell Transplantation
por: Buxbaum, Nataliya Prokopenko, et al.
Publicado: (2020)

Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021
por: Bacigalupo, Andrea, et al.
Publicado: (2021)

Case Report: Lessons Learned From Subsequent Autologous and Allogeneic Hematopoietic Stem Cell Transplantations in a Pediatric Patient With Relapsing Polychondritis
por: Veldkamp, Saskia R., et al.
Publicado: (2022)

Prognostic factors of second hematopoietic allogeneic stem cell transplantation among hematological malignancy patients relapsed after first hematopoietic stem cell transplantation: A single center study
por: Lu, Yue, et al.
Publicado: (2023)

Appropriate pre-transplant strategy for patients with myelodysplastic syndromes receiving allogeneic haematopoietic stem cell transplantation after myeloablative conditioning
por: Wang, Hong, et al.
Publicado: (2023)

Venetoclax or Ruxolitinib in Pre-Transplant Conditioning Lowers the Engraftment Barrier by Different Mechanisms in Allogeneic Stem Cell Transplant Recipients
por: Davis, Joanne E., et al.
Publicado: (2021)

A Case of Multiple Sclerosis—Like Relapsing Remitting Encephalomyelitis Following Allogeneic Hematopoietic Stem Cell Transplantation and a Review of the Published Literature
por: Das, Joyutpal, et al.
Publicado: (2020)

Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation
por: Ogonek, Justyna, et al.
Publicado: (2016)

Antibody based conditioning for allogeneic hematopoietic stem cell transplantation
por: Saha, Asim, et al.
Publicado: (2022)

Allogeneic hematopoietic stem cell transplantation in the COVID-19 era
por: Bordat, Jonathan, et al.
Publicado: (2023)

The impact of epigenetic modifications on allogeneic hematopoietic stem cell transplantation
por: Ktena, Yiouli P., et al.
Publicado: (2023)

The two-step approach to allogeneic hematopoietic stem cell transplantation
por: Ibikunle, Sikemi, et al.
Publicado: (2023)

Editorial: Novel Immunological Biomarkers for Allogeneic HSCT Outcome
por: Greco, Raffaella, et al.
Publicado: (2021)

HLA-C Incompatibilities in Allogeneic Unrelated Hematopoietic Stem Cell Transplantation
por: Tiercy, Jean-Marie
Publicado: (2014)

Pre-emptive Allogeneic Hematopoietic Stem Cell Transplantation in Ataxia Telangiectasia
por: Bakhtiar, Shahrzad, et al.
Publicado: (2018)

Management of Hepatitis B Virus in Allogeneic Hematopoietic Stem Cell Transplantation
por: Wu, Yibo, et al.
Publicado: (2021)

Improved Relapse-Free Survival in Patients With High Natural Killer Cell Doses in Grafts and During Early Immune Reconstitution After Allogeneic Stem Cell Transplantation
por: Minculescu, Lia, et al.
Publicado: (2020)

Preemptive interferon-α therapy could prevent relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation: A real-world analysis
por: Fan, Shuang, et al.
Publicado: (2023)

Allogeneic CAR T Cells: An Alternative to Overcome Challenges of CAR T Cell Therapy in Glioblastoma
por: Martínez Bedoya, Darel, et al.
Publicado: (2021)

Functional Reconstitution of Natural Killer Cells in Allogeneic Hematopoietic Stem Cell Transplantation
por: Ullah, Md Ashik, et al.
Publicado: (2016)

Bone Marrow GvHD after Allogeneic Hematopoietic Stem Cell Transplantation
por: Szyska, Martin, et al.
Publicado: (2016)

Donor-Specific Anti-HLA Antibodies in Allogeneic Hematopoietic Stem Cell Transplantation
por: Morin-Zorman, Sarah, et al.
Publicado: (2016)

Harnessing T Cells to Control Infections After Allogeneic Hematopoietic Stem Cell Transplantation
por: Basso, Sabrina, et al.
Publicado: (2020)

Cellular Therapeutic Approaches to Cytomegalovirus Infection Following Allogeneic Stem Cell Transplantation
por: Shafat, Manar S., et al.
Publicado: (2020)

Myeloid-Derived Suppressor Cells in the Context of Allogeneic Hematopoietic Stem Cell Transplantation
por: D'Aveni, Maud, et al.
Publicado: (2020)

Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation
por: Bonifazi, Francesca, et al.
Publicado: (2020)

Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia: Who, When, and How?
por: Loke, Justin, et al.
Publicado: (2021)

Generalist in allogeneic hematopoietic stem cell transplantation for MDS or AML: Epigenetic therapy
por: Yang, Guancui, et al.
Publicado: (2022)

Editorial: The Elephant in the Room: AML Relapse After Allogeneic Hematopoietic Cell Transplantation
por: Battipaglia, Giorgia, et al.
Publicado: (2022)

Demethylating agents in combination with CD7-targeted CAR-T for the successful treatment of a case with mixed-phenotype acute leukemia relapsed after allogeneic hematopoietic stem cell transplantation: A Case Report
por: Han, Ying, et al.
Publicado: (2023)

Low Intestinal IL22 Associates With Increased Transplant-Related Mortality After Allogeneic Stem Cell Transplantation
por: Ghimire, Sakhila, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qo2qk674avcr9ute2sr6b48btf